Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

UnitedHealth Group (NYSE:UNH) reported the fourth-quarter 2024 earnings and reaffirmed 2025 guidance. The company reported ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...

The year 2024 was exceptional for US stocks, with the broader market climbing over 23% and the […] (Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged ...

UnitedHealth Group is charging patients a markup for key life-saving ... The report, which levels the same allegations at CVS ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.